Zobrazeno 1 - 10
of 57
pro vyhledávání: ''
Autor:
Kohei Shitara, Toshihiko Doi, Hisashi Hosaka, Peter Thuss-Patience, Armando Santoro, Federico Longo, Ozgur Ozyilkan, Irfan Cicin, David Park, Aziz Zaanan, Carles Pericay, Mustafa Özgüroğlu, Maria Alsina, Lukas Makris, Karim A. Benhadji, David H. Ilson
Publikováno v:
Scientia
Background Trifluridine and tipiracil (FTD/TPI) demonstrated survival benefit vs placebo and manageable safety in previously treated patients with metastatic gastric/gastroesophageal junction cancer (mGC/GEJC) in the randomized, placebo-controlled, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a45e883686e60f91bacc0ff8cb91867
https://hdl.handle.net/11351/8082
https://hdl.handle.net/11351/8082
Autor:
Mette-Triin Purde, Rebekka Niederer, Nikolaus B. Wagner, Stefan Diem, Fiamma Berner, Omar Hasan Ali, Dorothea Hillmann, Irina Bergamin, Markus Joerger, Martin Risch, Christoph Niederhauser, Tobias L. Lenz, Martin Früh, Lorenz Risch, David Semela, Lukas Flatz
Publikováno v:
Purde, Mette‑Triin; Niederer, Rebekka; Wagner, ikolaus B.; Diem, Stefan; Berner, Fiamma; Hasan Ali, Omar; Hillmann, Dorothea; Bergamin, Irina; Joerger, Markus; Risch, Martin; Niederhauser, Christoph; Lenz, Tobias L.; Früh, Martin; Risch, Lorenz; Semela, David; Flatz, Lukas (2022). Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. Journal of cancer research and clinical oncology, 148(3), pp. 647-656. Springer 10.1007/s00432-021-03870-6
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology
Purpose Immune checkpoint inhibitor (ICI)-induced hepatitis belongs to the frequently occurring immune-related adverse events (irAEs), particularly with the combination therapy involving ipilimumab and nivolumab. However, predisposing factors predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::812bf92bad1e3210e93f155d71738545
https://boris.unibe.ch/162047/1/Purde2021_Article_PresenceOfAutoantibodiesInSeru.pdf
https://boris.unibe.ch/162047/1/Purde2021_Article_PresenceOfAutoantibodiesInSeru.pdf
Publikováno v:
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology
Cellular Oncology, Vol 32, Iss 1-2, Pp 57-65 (2010)
Cellular Oncology, Vol 32, Iss 1-2, Pp 57-65 (2010)
Background: Patients with gastric cancer (GC) have a poor survival and biologicals such as Trastuzumab have not been used routinely in these patients. Existing data on HER2 expression and its clinical relevance in GC are still limited and controversi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1c3dd546244ad55cb07c72b3e643d86
https://ora.ox.ac.uk/objects/uuid:7bfe1b69-4071-48f2-8d28-7dea51965e5e
https://ora.ox.ac.uk/objects/uuid:7bfe1b69-4071-48f2-8d28-7dea51965e5e
Autor:
Monserrat Mangas, Flora López, Marc Diez, Juana María Cano, Alberto Carmona-Bayonas, Alfonso Martín Carnicero, Aitziber Gil-Negrete, Manuel Cánovas, Marcelo Garrido, Paula Cerdá, Paola Pimentel, Alicia Hurtado, Marta Martín Richard, Federico Longo, Carolina Hernández Pérez, Ana Montes, Rosario Vidal Tocino, Eva Martínez de Castro, Aranzazu Arias-Martinez, Javier Gallego, Mónica Granja, Laura Visa, Nieves Martinez Lago, Carles Pericay Pijaume, Natalia Castro Unanua, Avinash Ramchandani, Raquel Hernández, Ana Custodio, Tamara Sauri, Paula Jiménez-Fonseca, Gema Aguado, María Luisa Limón, Mariona Calvo, Aitor Azkarate
Publikováno v:
Scientia
Gastric Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Gastric Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Background The purpose of our study was to develop an online calculator to estimate the effect of docetaxel triplets (DPF) in first line of advanced gastric cancer (AGC), and to assess the external validity of docetaxel trials in individual patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82837869875d5aad20b11f5093a89906
https://hdl.handle.net/11351/7737
https://hdl.handle.net/11351/7737
Autor:
Lukas Schollenberger, Christoph Thomssen, Slavomir Krajnak, Nadia Harbeck, Thomas Decker, Christian Ruckes, Tanja Fehm, Marcus Schmidt, Christian Rose
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Metronomic chemotherapy (MCT) is an increasingly used treatment option in hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) advanced/metastatic breast cancer (MBC) after failure of endocrine-based the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d71e18d1f5a367f18fa6e6cf0e457306
Autor:
Ignacio Ruz-Caracuel, Patricia Ruiz, Andrés Redondo, Álvaro López-Janeiro, Laura Yébenes, Alejandro Gallego, Victoria Heredia-Soto, Jorge L Ramón-Patino, Alberto Berjón, David Hardisson, Marta Mendiola, Alicia Hernández, Alberto Peláez-García
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Virchows Archiv
instname
Virchows Archiv
Low-grade and early-stage endometrioid endometrial carcinomas (EECs) have an overall good prognosis but biomarkers identifying patients at risk of relapse are still lacking. Recently, CTNNB1 exon 3 mutation has been identified as a potential risk fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0c7fb0523a4159ae90bb1464bb2fea
http://hdl.handle.net/10486/700725
http://hdl.handle.net/10486/700725
Autor:
Allaudin Issa, Vijay K Sangar, Peter-Karl Bode, Josias Bastian Grogg, Anja Lorch, Christian D. Fankhauser, Jordi Nicola Fronzaroli, Daniel Eberli, Noel W. Clarke, Joerg Beyer, Thomas Hermanns, Pedro Oliveira
Publikováno v:
Grogg, Josias Bastian; Fronzaroli, Jordi Nicola; Oliveira, Pedro; Bode, Peter-Karl; Lorch, Anja; Issa, Allaudin; Beyer, Joerg; Eberli, Daniel; Sangar, Vijay; Hermanns, Thomas; Clarke, Noel William; Fankhauser, Christian Daniel (2021). Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data. Journal of cancer research and clinical oncology, 147(9), pp. 2671-2679. Springer 10.1007/s00432-021-03533-6
Journal of Cancer Research and Clinical Oncology
Journal of Cancer Research and Clinical Oncology
Purpose Mesothelioma of the tunica vaginalis testis (MTVT) is a rare tumor, and currently, there are no published treatment recommendations. Methods We performed a systematic literature review and synthesized clinical presentation, clinicopathologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10de6f5f9e5ad6560233ed61a29e8db5
Autor:
Ana Custodio, Carolina Hernández Pérez, Mónica Granja, Aitor Azkarate, Aitziber Gil-Negrete, Laura Visa, Manuel Cánovas, Carles Pericay Pijaume, Tamara Sauri, Patricia Morales del Burgo, Gema Aguado, Felipe Alvarez-Manceñido, Olbia Serra, Paula Jiménez-Fonseca, Nieves Martinez Lago, M. Luisa Limon, Maria Alsina, Alicia Hurtado, Aranzazu Arias-Martinez, Alfonso Martín Carnicero, Javier Gallego, Ana Montes, P. Reguera, Paola Pimentel, Juana María Cano, Rosario Vidal Tocino, Virginia Arrazubi, Alberto Carmona-Bayonas, Diego Cacho Lavin, Alba Martinez-Torron, Avinash Ramchandani, Marta Martín Richard, Raquel Hernández, Flora López
Publikováno v:
Gastric Cancer
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-FISABIO. Repositorio Institucional de Producción Científica
Background Advanced esophageal adenocarcinoma (EAC) is generally treated similarly to advanced gastroesophageal junction (GEJ-AC) and gastric (GAC) adenocarcinomas, although GAC clinical trials rarely include EAC. This work sought to compare clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6610ee161c1b474b11a4778f667108
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4917
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4917
Autor:
Ulrike Stein, Alexander Arnold, Erika Berg, Beate Rau, C Treese, Michael Hummel, M. von Winterfeld, Severin Daum
Publikováno v:
Clinical & Translational Oncology
Introduction The tight junction molecule Claudin 18.2 is selectively expressed in healthy and malignant gastric epithelial tissue and is a promising therapy target for high Claudin 18.2 expressing adenocarcinomas of the esophagogastric junction and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba822c13c78945e6c5883f885a614365
http://edoc.mdc-berlin.de/19016/2/19016suppl.zip
http://edoc.mdc-berlin.de/19016/2/19016suppl.zip
Autor:
Mehmet Zengin
WOS: 000497411800002 PubMed: 31748877 Purpose Although local inflammatory response (LIR) is a reliable survival marker in colon cancers (CCs), there is no consensus on its use in daily practice. We investigated the prognostic value of LIR in a highly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f863fcdf9c892992e4d07136f931937
https://hdl.handle.net/20.500.12587/2756
https://hdl.handle.net/20.500.12587/2756